Top 5 Players Account for Over 62% Revenue Share of the Histopathology Testing Equipment Market
The rapidly advancing diagnostics space has resulted in development of various companies involved in production of diagnostic equipment as well as distribution of testing apparatus and assemblies.
The histopathology testing equipment market is no exception, wherein top five companies involved in the development of histopathology testing equipment account for a significant share of the overall market revenue.
Top companies such as
- Thermo Fisher Scientific
- Hoffman-la-Roche Ltd.
- Leica Biosystems
- Agilent Technologies Inc.
- Merck KGaA
collectively account for a revenue share of over 62% in the histopathology testing equipment market.
Increasing awareness regarding cancer screening coupled with higher demand for advanced histopathology testing equipment from diagnostic centers are expected to provide potential avenues of growth for tier 1 manufacturers.
These companies are more focused on new product launches, expansion of their current product lines.
They are also involved in acquisitions to expand their current footprint in a bid to enhance their histopathology testing equipment sales channels in the diagnostic space.
For instance, in 2017, Agilent Technologies Inc., acquired 100% of the stock of Multiplicom NV, a leading diagnostics company in Europe, in a bid to strengthen Agilent’s presence in the histopathology testing equipment market place by leveraging Multiplicom’s advanced diagnostic kits and testing technology.
Increasing Incidence of Melanoma Fuelling Use of Histopathology Testing Equipment
Increasing incidence of melanoma has been a cause of major concern among individuals. According to United Nations Environment Program, around 200,000 malignant melanoma cases occur every year.
Skin Cancer Foundation has revealed that in the past decade (from 2008 till 2018), the number of melanoma cases have increased by about 53 percent annually worldwide.
The demand for histopathological analysis of melanoma has witnessed an increase in the last decade, owing to growing referrals from general practitioners and growing awareness among the general population.
These factors have increased the importance of systematic and unified approach toward melanoma histopathology.
Anatomic Pathology Service Providers and Centers to Adopt Histopathological Testing Equipment
Increasing demand for anatomic pathology services on the back of a significant rise in the use of anatomic testing instruments and consumables such as kits is expected to influence the demand for histopathology testing equipment.
Anatomic instruments are used to morphologically examine cells and tissues to diagnose chronic diseases at reasonable costs.
Recently, anatomic diagnostic centers have been equipped with advanced equipment to carry out effective tissue processing based on histological assessment of samples (H&E preparation) of biopsies that can be carried out in less than 48 hours.
This aspect has triggered the use of histopathology sample in turn triggering demand for histopathology testing equipment.
Clinical Autopsy and Histopathology – Another Histopathology Testing Equipment Sales Funnel for Manufacturers
Use of histopathology testing equipment in clinical autopsy has been influential in driving sales of histology instruments and kits.
Clinical autopsy includes diagnosis of infectious diseases of different types including viruses, bacteria, helminths and protozoa.
Majority of these are identified using histopathology using immunohistochemistry and stains that a vital part in clinical autopsy.
Consequently, growing application in clinical autopsy is likely to impact sales of histopathology testing equipment across hospitals.
Avail customized purchase options for your needs
AI in Histopathology Testing Equipment – An Upcoming Trend
Technological advances in digitalization has not left any sector untouched and histopathology is no exception. The adoption of artificial intelligence (AI) has been witnessed in the histopathology testing equipment space.
Artificial intelligence can be used to carry out critical processes in the histopathology testing equipment such as counting T-cells that increases the buffer time for researchers to carry out other vital tasks.
The adoption of artificial intelligence in histopathology testing equipment space can ensure efficient image analysis and automated diagnosis facilitating superior performance quotient.
The proliferation of artificial intelligence in the histopathology testing equipment is likely to revolutionize the histopathology testing equipment market in the years to follow.
The report on histopathology testing equipment market includes assessment on key players involved in the manufacturing of histopathology testing equipment.
Key aspects of histopathology testing equipment market players such as SWOT analysis, product portfolio analysis, innovations and developments, mergers and acquisitions, and key financials are included in the report.
The histopathology testing equipment market report covers profiles of key players such as Thermo Fisher Scientific, Hoffman-La-Roche Ltd., and Leica Biosystems.
Companies in the histopathology testing equipment market are largely involved in product development. In 2018, Leica Biosystems has developed rotary microtome solutions that offer superior quality sectioning and improved user safety.
The company has also launched next generation BOND-III ISH and IHC stainers. Likewise, Roche Diagnostics has launched VENTANA DP 200, a digital pathology device that connects with VENTANA iScan HT and iScan Coreo.
Companies in the histopathology testing equipment market are also involved in strategic alliances and acquisitions.
For instance, Bio-Techne has signed an agreement to acquire Exosome Diagnostics with which Bio-Techne can enhance its position in the histopathology testing equipment space, particularly in the rapidly expanding non-invasive liquid biopsy.
In June 2018, Merck KGaA entered into an agreement with HistoCyte Laboratories Ltd., to sell products for in situ hybridization and immunohistochemistry.
Under this agreement, Merck will deploy its sales expertise to market HistoCyte’s pathology slide controls in the US market and other geographies.
This strategic collaboration will also enhance HistoCyte’s global reach in histopathology testing equipment space, particularly in the US market by leveraging Merck’s leadership.
An Adaptive Approach to Modern-day Research Needs
Histopathology testing equipment are tools that are used to prepare samples and examine tissues. Histopathology testing equipment are used in medical laboratories and in biological examination.
Histopathology testing equipment consist of various types of instruments such as tissue processors, cover slippers and microtome and cryostats.
Histopathology testing equipment consumables include reagents, probes and kits to name a few.
Histopathology testing equipment is used across various applications such as disease diagnosis and drug discovery by end users including hospitals and research laboratories.
About the Report
The report titled “Histopathology Testing Equipment Market Forecast, Trend Analysis and Competition Tracking – Global Market Insights 2018-2028” is a comprehensive compilation that reveals a cohort of insights on the demand and sales of histopathology testing equipment in various end use applications across regions.
Various aspects impacting the growth of the histopathology testing equipment market including trends, drivers, and restraints and are covered in the histopathology testing equipment market report.
Assessment on historical data of histopathology testing equipment market, current histopathology testing equipment market scenario and future projections of histopathology testing equipment market are included in the report.
Interested to Procure The Data
The histopathology testing equipment market has been segmented in detail to cover every angle of the histopathology testing equipment market.
The histopathology testing equipment market is segmented on the basis of product type, by application, by end user and by region.
The product type category is further classified into instruments (tissue processors, slide stainers, cover slippers, microtome & cryostats, microscopes, and tissue embedding equipment) and consumables (reagents & antibodies, probes and kits).
Histopathology testing equipment applications such as research applications, drug discovery and disease diagnostics are included in the application segment.
End users of histopathology testing equipment include hospital-based laboratories, diagnostic centers and research organizations.
The histopathology testing equipment market has been analyzed across regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China and Japan (APECJ), Japan, China and Middle East and Africa (MEA).
Additional Questions Answered
Apart from the above mentioned insights, the histopathology testing equipment market report also provides answers to additional questions such as:
- Which is the most attractive region for histopathology testing equipment market?
- Can sales of histopathology testing equipment in Asia Pacific excluding China and Japan surpass those in Western Europe in the coming years?
- At what rate are the sales of histopathology testing equipment in diagnostic centers growing?
- Which is the most lucrative application area for histopathology testing equipment?
- Which histopathology testing equipment product type is likely to gain high traction in the coming years?
The histopathology testing equipment market report is crafted using a robust research methodology that is a combination of secondary and primary research techniques.
The information obtained from these methodologies is combined with intelligence from external sources that enables higher degree of accuracy of data with respect to sales and demand of histopathology testing equipment.
- FAQs -
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.